BAC
Bank of America Corporation
BAC has a slight edge over SHG overall, supported by stronger modeled upside and lower modeled downside.
SHG
Shinhan Financial Group Co., Ltd.
SHG's outlook is improving, though it still trails on the overall score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
SHG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
SHG's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like SHG.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
SHG PE Valuation
SHG has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
SHG Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for SHG, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over SHG on earnings, with stronger typical year-over-year growth.
SHG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $8.36 | +22% |
| Q1 2026 | $7.72 | +17% |
| Q4 2025 | $7.42 | +18% |
| Q3 2025 | $7.14 | +9.5% |
| Q2 2025 | $6.88 | +9.2% |
| Q1 2025 | $6.61 | +9.1% |
| Q4 2024 | $6.31 | +3.8% |
| Q3 2024 | $6.52 | +13% |
SHG's earnings per share have climbed steadily: $8.36 over the past year, up 22% from the year before, and higher year over year for eight quarters in a row.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over SHG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
SHG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $7.5B | +13% |
| Q1 2026 | $6.5B | +2% |
| Q4 2025 | $6.6B | -2.6% |
| Q3 2025 | $6.3B | -4.6% |
| Q2 2025 | $6.6B | +0.1% |
| Q1 2025 | $6.4B | -0.9% |
| Q4 2024 | $6.8B | -1.7% |
| Q3 2024 | $6.6B | +5.6% |
SHG's revenue grew through 2023 and has held roughly level since: $7.5B last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 36% | +13 points |
| Q1 2026 | 25% | +2 points |
| Q4 2025 | 10% | +3.6 points |
| Q3 2025 | 23% | +3.2 points |
| Q2 2025 | 23% | +2.3 points |
| Q1 2025 | 23% | +2.7 points |
| Q4 2024 | 6.6% | -1.9 points |
| Q3 2024 | 20% | +1 points |
SHG has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
SHG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$350.4M | +$3B |
| Q1 2026 | $9.8B | +107% |
| Q4 2025 | -$3.8B | -$504.2M |
| Q3 2025 | $9.2B | +86% |
| Q2 2025 | -$3.3B | -$2.1B |
| Q1 2025 | $4.8B | +$5.8B |
| Q4 2024 | -$3.3B | +$379.3M |
| Q3 2024 | $4.9B | +$9.7B |
SHG has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over SHG on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
SHG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -867K shares |
| 1 year | -1.2% | -5.8M shares |
| 3 years | -7.5% | -39.1M shares |
| 5 years | -9.8% | -52.5M shares |
| Available history | +0.1% | +662K shares |
SHG has 482M diluted shares, down 1.2% from a year ago, with $974M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $228.1M |
| Q1 2026 | $296.4M |
| Q4 2025 | $251.8M |
| Q3 2025 | $197.8M |
| Q2 2025 | $280.1M |
| Q1 2025 | $207M |
| Q4 2024 | $187.3M |
| Q3 2024 | $112.5M |
SHG spent $974M buying back its own shares over the past year, up 24% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC has the edge over SHG on leverage, with a lower net debt burden relative to earnings.
SHG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 11.0x | High |
| Q1 2026 | 12.4x | High |
| Q4 2025 | 14.0x | High |
| Q3 2025 | 12.3x | High |
| Q2 2025 | 13.5x | High |
| Q1 2025 | 13.0x | High |
| Q4 2024 | 14.9x | High |
| Q3 2024 | 13.5x | High |
SHG's net debt is about 11 years of its operating earnings (EBITDA), down from 13 years a year ago. Net leverage isn't a meaningful measure for financial services companies like SHG.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
SHG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.3 | Neutral |
| Stochastic | 4.9 | Oversold |
SHG's weekly RSI is 40 (neutral) and its Stochastic is 5 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
SHG PE vs Financial Services Sector
| Metric | SHG | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
SHG has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
SHG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $70.5 | 9.5% below |
| 20 week MA | $73.4 | 13% below |
| 50 week MA | $66.6 | 4.2% below |
| 100 week MA | $54.3 | 17% above |
| 200 week MA | $43.3 | 47% above |
SHG has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
SHG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $39.6 | $30.4 | -23% |
| 2021 | $30.4 | $32.0 | +5.4% |
| 2022 | $32.0 | $29.3 | -8.4% |
| 2023 | $29.3 | $30.8 | +5.1% |
| 2024 | $30.8 | $33.2 | +7.8% |
| 2025 | $33.2 | $54.0 | +63% |
| 2026 YTD | $54.0 | $63.8 | +18% |
SHG has the edge over BAC on returns for 2026, with the stronger performance.